Guest Open Access Plus | Free Content | About | Sign in | New Users: Sign up | Mark List  

Current Medicinal Chemistry

Volume 15 Issue 13
ISSN: 0929-8673
eISSN: 1875-533X

 

   All Titles

  Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemias
  pp.1274-1287 (14) Authors: Giuseppe Leone, Francesco D'Alo, Giuseppe Zardo, Maria Teresa Voso, Clara Nervi
 
 
      Abstract

Epigenetic mechanisms affecting chromatin structure contribute to regulate gene expression and assure the inheritance of information, which are essential for the proper expression of key regulatory genes in healthy cells, tissues and organs. In the medical field, an increasing body of evidence indicates that altered gene expression or de-regulated gene function lead to disease. Cancer cells also suffer a profound change in the genomic methylation patterns and chromatin status. Aberrant DNA methylation patterns, changes in chromatin structure and in gene expression are common in all kind of tumor types. However, studies on leukemias have provided paradigmatic examples for the functional implications of the epigenetic alterations in cancer development and progression as well as their relevance for therapeutical targeting.

 
  Keywords: MDS, AML, HDAC inhibitors, hypomethylating agents, epigenetics
  Affiliation: Istituto di Ematologia, Universita Cattolica S. Cuore, L.go A. Gemelli, 1, 00168 ROMA, Italy.
 
  Key: New Content Free Content Open Access Plus Subscribed Content

Bentham Science Publishers
www.benthamscience.com

 

  Copyright © 1994 - 2014   Bentham Science Publishers